Rapport Therapeutics, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Jun 2023 | — | — | $79.5M |
| Sep 2023 | — | — | $159.4M |
| Dec 2023 | $14.5M | $155.4M | $70.2M |
| Mar 2024 | — | — | $74.3M |
| Jun 2024 | $9.2M | $346.1M | $110.2M |
| Sep 2024 | $8.0M | $331.1M | $39.3M |
| Dec 2024 | $9.5M | $314.9M | $56.8M |
| Mar 2025 | $16.2M | $302.1M | $57.6M |
| Jun 2025 | $22.0M | $285.5M | $55.1M |
| Sep 2025 | $23.7M | $535.3M | $251.4M |
| Dec 2025 | $27.8M | $512.4M | $52.6M |
| Mar 2026 | $26.1M | $497.6M | $78.1M |
| Jun 2026 | $36.1M | $459.0M | $63.6M |